PCA Stock Overview
PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
PCAS SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €8.00 |
| 52 Week High | €8.85 |
| 52 Week Low | €5.80 |
| Beta | 0.37 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 11.11% |
| 3 Year Change | -22.33% |
| 5 Year Change | -41.09% |
| Change since IPO | 152.85% |
Recent News & Updates
Recent updates
Statutory Earnings May Not Be The Best Way To Understand PCAS' (EPA:PCA) True Position
Sep 14
Is PCAS (EPA:PCA) A Risky Investment?
Dec 19Is PCAS (EPA:PCA) Weighed On By Its Debt Load?
May 24Did You Miss PCAS' (EPA:PCA) 48% Share Price Gain?
Mar 02PCAS'(EPA:PCA) Share Price Is Down 48% Over The Past Three Years.
Nov 25Shareholder Returns
| PCA | FR Life Sciences | FR Market | |
|---|---|---|---|
| 7D | 0% | -4.6% | 2.2% |
| 1Y | 11.1% | -8.0% | 3.2% |
Return vs Industry: PCA exceeded the French Life Sciences industry which returned -22% over the past year.
Return vs Market: PCA matched the French Market which returned 10.3% over the past year.
Price Volatility
| PCA volatility | |
|---|---|
| PCA Average Weekly Movement | 3.0% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: PCA has not had significant price volatility in the past 3 months.
Volatility Over Time: PCA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 1,178 | Jean-Louis Martin | www.pcas.com |
PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS
PCAS SA Fundamentals Summary
| PCA fundamental statistics | |
|---|---|
| Market cap | €109.93m |
| Earnings (TTM) | €8.76m |
| Revenue (TTM) | €229.96m |
12.5x
P/E Ratio0.5x
P/S RatioIs PCA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCA income statement (TTM) | |
|---|---|
| Revenue | €229.96m |
| Cost of Revenue | €81.51m |
| Gross Profit | €148.45m |
| Other Expenses | €139.69m |
| Earnings | €8.76m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 64.55% |
| Net Profit Margin | 3.81% |
| Debt/Equity Ratio | 2,725.7% |
How did PCA perform over the long term?
See historical performance and comparison